Management of Skin and Soft-Tissue Infections Before and After Clinical Pathway Implementation

Clinical Pediatrics
Courtney E NelsonFran Balamuth

Abstract

We evaluated if the introduction of a clinical pathway for skin and soft-tissue infections (SSTIs) would reduce methicillin-resistant Staphylococcus aureus (MRSA)-directed therapy for simple cellulitis and antibiotic use for simple abscess after drainage. We compared the treatment of SSTI during a 3-month prepathway and 11-month postpathway period. We included patients 57 days to 18 years old discharged from the emergency department (ED) with a diagnosis of cellulitis or abscess. Balancing measures included 72-hour revisit rate and ED length of stay (LOS). A total of 291 patients prepathway and 781 patients postpathway were included. The proportion of patients with simple cellulitis prescribed MRSA-directed therapy decreased from 81% to 54% postpathway. The proportion of patients with a drained abscess prescribed systemic antibiotics decreased from 88% to 75%. There was no increase in 72-hour revisit rates (3.8% vs 3.2%, P = .64) or ED LOS (2.8 vs 2.7 hours, P = .05).

References

Aug 18, 2006·The New England Journal of Medicine·Gregory J MoranUNKNOWN EMERGEncy ID Net Study Group
Jul 30, 2008·Archives of Internal Medicine·Adam L HershRalph Gonzales
Apr 8, 2010·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Rakesh D MistryElizabeth R Alpern
Sep 16, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy C JenkinsWilliam J Burman
Jan 7, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Catherine LiuUNKNOWN Infectious Diseases Society of America
Feb 1, 2011·The American Journal of Emergency Medicine·Larissa MayGillian Schmitz
Nov 23, 2013·The American Journal of Medicine·Hermione J HurleyTimothy C Jenkins
Jun 21, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dennis L StevensJames C Wade
Jul 19, 2014·The Western Journal of Emergency Medicine·Rakesh D MistryAdam L Hersh
Jul 29, 2015·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Peter M YarbroughKensaku Kawamoto

❮ Previous
Next ❯

Citations

Dec 8, 2019·European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society·Annika RühleFrank J P Beeres

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.